• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Median enhances cancer lesion software

Article

Median Technologies has updated its Median LMS (Lesion Management Solution) software toevaluate, follow and report on changes involving of cancerous lesions seen on CT images from the neck to the pelvis.

Median Technologies has updated its Median LMS (Lesion Management Solution) software to
evaluate, follow and report on changes involving of cancerous lesions seen on CT images from the neck to the pelvis. The enhanced software, slated to debut at RSNA 2009, generates a single report for the quantitative management of patient response to therapy, according to the company. It is designed for routine clinical use, as well as in multicenter clinical trials. Median LMS automates the initial evaluation and follow-up of cancerous lesions identified in CT images of the thorax, abdomen and pelvis, automatically generating a standardized oncologic report and centralizing all lesion information. In so doing, it helps in the assessment of patient response to therapy, assisting in an evaluation of the effectiveness drugs. This can be especially important in clinical trials, when experimental drugs require standardized measurement and reporting of target lesion response, according to the company.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.